Member Info for bignose58

Master Investor is up n running again.

Had an invite but wont be going since it'll be the usual BS with no mention of money trees. I wonder if Jim will be taking his acoustic Gibson Les Paul.....cough....

Wont hold my breath for a JG visit to ramp the company or indeed the product.

Yup, just the same old news and nothing new.

It certainly has been a long road of misinformation, lies, total incompetence and a total lack of respect towards all shareholders, those that have stayed the distance and those who couldn't take it any longer and jumped ship.

My concern now is; if and when ERP start getting an income stream, will their incompetence just waste it away on dubious investments or will they just wash it all down the toilet for the same result ??? Hopefully the SP will have jumped in multiples of the current level giving a much better market valuation allowing us remaining sufferers to also jump ship and leave with a half decent profit for the time invested never to look back on the shambles of a BOD. CEO and fat controller. :-)

You could indeed be right in your speculation. Even better if the peak sp is a lot higher than contemplated. Also, it would be extremely positive if they manage to get a us licensee to cover the FDA costs as well as not having to pay JG for doing SFA (there’s another one for ya….lol). Mind you that would mean a license agreement is needed in the next few months, although it may depend on the FDA’s response to the phase II submission. I wouldn’t be surprised if he change in tact regarding the FDA process has not come from the license talks.

Easily done The.Italian given the number of acronyms that have recently been flying around.

It’s not the number of sufferers that’s the problem, it’s the number who are willing to come out of the closet to buy it, which has not been addressed by anyone in the company or the marketing crowd who produced that report which won’t mean anything unless they can motivate sufferers to come forward.

WRT China. Even if half the population are poor and live in rural areas where they won’t have access to the product and more likely won’t even know of its existence, that still leaves approx 700mill ppl => 87.5mill sufferers, which, even if they achieve 5% of that in sales is still around 500mill usd.

Add onto that a similar figure for the states (although half of the above figure in sufferers, assuming no poor due to insurance, and a can will be more expensive), we are still looking at a reasonable number to catapult the sp to more than 1HK$ Just to begin with as sales pick up and new investors gamble and jump onboard. Speculative opinion on my part, but certainly not unreasonable. And I’m not even including Canada or South America who may approve based on the FDA approval.

Of course that’s assuming they can get their act together with respect to obtaining a US license agreement which, in my opinion, is taking far longer than it should given they have been in constant talks since 2014.

Keith, it’ll be before you are 65 that’s for sure, you can then retire early like most long term investors here who invested in their teens……lol

Bothwell,

You are indeed right. No matter how long JG keeps delaying it through incompetence and can keep getting his annual salary no matter what, it is inevitable. Both the US and Chinese authorities will eventually approve the product for sale.

Not sure what that Lat word was as I don’t recall typing anything ;-), but I suspect the system is in agreement and added it’s own word something along the lines of SHTIE…lol

Keith, as usual, you don’t disappoint in your writings. Off piste indeed. What a great use for the word which I’ve only ever done in the Alps, but that’s another story. Indeed, they are a total shambles. And as can be seen from experience, JM is only interested in his own gains. This product should have been out there a long time ago, however. I still think there is scope for income if (and it’s a big IF) the company manage to get China and the US sorted. Even with a small amount of sales (% wise) we the company should have a rerate back to at least for us to be in profit. The question is when.

Hopefully China have started their recruitment and the FDA is agreeable to the phase 3 starting in Q1 or at least Q2 this year. We can forget about Israel as that’s just a joke, just like our BOD and CEO…. S******.

The.Italian,

With respect to tour statement regarding capable CEO's. That is indeed the case for the larger companies which have various departments etc etc since the CEO cannot be expected to know it all, although they generally have a small amount of relevant experience, however. With the size of this company, which only has one product (forget the DLI as it was an add on only a year ago), the CEO should have some knowledge and experience in this particular field. He should have had at least a basic knowledge of commercialising a product. Instead we have been led by a CEO with a so called law degree who's only experience is to find investors to hand over money which is used to pay his salary, which he no longer has the ability to do since once bitten twice shy comes to mind. All those who have invested in cash calls have lost the shirts off their backs given the sp they bought in at the time (and that was at a discount).

The person to blame here is Jim Mellon since he has allowed it to go on. I am pretty sure if the company had employed a person with even a small inkling of experience in pharma, we would be in a different position today.

Both need to go, but unfortunately whilst JM holds all the cards, it will never happen. He is as incompetent as anyone could ever get in business otherwise we wouldn't be where we are now. That's my two pennyworth for what its worth, which I have been posting for quite sometime now. (I have even emailed JM a few times suggesting JG and the BOD should go and be replaced with people with at least a modicum of pharma experience, but as can be seen, Its all been ignored).

Generic since they have no clue what pharma or anything else related is........ :-)

Or maybe not.......

Remember, HK has been closed for a few days because of CNY and I am sure JG will take all holidays in all regions no matter where he is located (currently domiciled in Scotland) and will still get paid for it as regular as clockwork.

That said, we should be getting the profit warning towards the end of this month.... as usual as clockwork too....lol

Morning The.Italian,

As usual they are playing with our minds.....Its all part of their plan for world dominance in pharma..........

Morning The.Italian,

Yes, I had noticed it, but like every announcement they gen mean one thing and do something else. They even go on to say that some would be used to invest, which as we know from the last 10+ years is just BS. Especially as there will be nothing to invest. The usual smoke and mirrors.

I wonder where that will leave the DLI holders, if it all goes tist up ?

Some interesting points that POM has made which could be considered a red flag ?

Since JM holds approx 23.47% of ERP through his controlled entities, including Galloway, why not have Galloway increase that share stake rather than take money out of the company ?.

Why are the convertible loan note holders even considering putting in place a mechanism to quickly dispose of DVP shares to pay down their notes which does not give a signal that they are interested in converting loans to ERP stock ?

Its understandable they want to avoid all the shenanigans to dispose of stock should the DVP price spike but not the intended use of the proceeds which does nothing to further develop the ERP business.

Of course, although there may be some personal logical reason in what they are doing (lining their own pockets etc), based on history and as has clearly been shown before, they actually don't have any business acumen and any clue as to what they are doing........lol

Morning The.Italian,

Probably as a result of positive US cues which saw another blue day on the NYSE

So, how remote is there a chance that they are making the announcement to possibly offload the shares because the DVP is going to be bought out or some major deal is on the cards ? Could all the other shtie included just be to hide the possibility of it being considered as insider info ??? I grant you, highly unlikely since we all know they know nuffin about nuffin, but it is worth a speculate….lol.

CNY tomorrow (year of the tiger and a new moon n all that) so HK will be closed for the next couple of days.

Seems someone has been reading our discussions on the disposal of DVP shares.

https://www.endurancerp.com/ICMServlet/download/13-2527-4098/eAnn_Major%20Transaction.pdf

What I find interesting is that by making this announcement would surely indicate no worthwhile license deals are that close to being signed or they are below par. Also, I note that it would appear the company has had a loan from Galloway in the last 6 months. “loans provided by Galloway Limited in the principal amount of approximately US$10.88 million“. When did they do this and why weren’t shareholders advised given its between 20 and 25% of the market cap ? Certainly more BS about increasing shareholder value.

Certainly agree with that. Even JG was probably forced to make the loan after the Yooya debacle, which he did on preferential terms, otherwise possibly lose the company, his job and his 1.5mill usd salary which was probably subsequently guaranteed by JM as safe. (Hands in the air as I’m just speculating).

I’m sure the company will never become the billion dorrar company as touted after the PLE TO and now as a longevity company as they just simply don’t have the know how. Wrong people and certainly no expertise.

I haven’t followed all the background goings on in ANIC, but certainly not surprised JM thinks he can get a piece of the action. Only time will tell on that one, but given his historic achievements with other companies. DBC, LIFE, PEBI, etc, I expect it will also go to rats shti…..at the expense of the pi.. :-)